<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06508</article-id><article-id pub-id-type="doi">10.7554/eLife.06508</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-27656"><name><surname>McCormack</surname><given-names>Ryan M</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-27657"><name><surname>de Armas</surname><given-names>Lesley R</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-27658"><name><surname>Shiratsuchi</surname><given-names>Motoaki</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27659"><name><surname>Fiorentino</surname><given-names>Desiree G</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27639"><name><surname>Olsson</surname><given-names>Melissa L</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27660"><name><surname>Lichtenheld</surname><given-names>Mathias G</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27661"><name><surname>Morales</surname><given-names>Alejo</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27638"><name><surname>Lyapichev</surname><given-names>Kirill</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-27663"><name><surname>Gonzalez</surname><given-names>Louis E</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27664"><name><surname>Strbo</surname><given-names>Natasa</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27665"><name><surname>Sukumar</surname><given-names>Neelima</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, College of Veterinary Medicine</institution>, <institution>Cornell University</institution>, <addr-line><named-content content-type="city">Ithaca</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27666"><name><surname>Stojadinovic</surname><given-names>Olivera</given-names></name><aff><institution content-type="dept">Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27667"><name><surname>Plano</surname><given-names>Gregory V</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23097"><name><surname>Munson</surname><given-names>George P</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27668"><name><surname>Tomic-Canic</surname><given-names>Marjana</given-names></name><aff><institution content-type="dept">Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27669"><name><surname>Kirsner</surname><given-names>Robert S</given-names></name><aff><institution content-type="dept">Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13666"><name><surname>Russell</surname><given-names>David G</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, College of Veterinary Medicine</institution>, <institution>Cornell University</institution>, <addr-line><named-content content-type="city">Ithaca</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-24224"><name><surname>Podack</surname><given-names>Eckhard R</given-names></name><aff><institution content-type="dept">Microbiology and Immunology</institution>, <institution>U. Miami, School of Medicine</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country><email>epodack@miami.edu</email></aff><xref ref-type="fn" rid="conf5"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1063"><name><surname>Cossart</surname><given-names>Pascale</given-names></name><role>Reviewing editor</role><aff><institution>Institut Pasteur</institution>, <country>France</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>09</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06508</elocation-id><supplementary-material><ext-link xlink:href="elife-06508-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>15</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, McCormack et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>McCormack et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Perforin-2 (MPEG1) is a pore-forming, antibacterial protein with broad-spectrum activity. Perforin-2 is expressed constitutively in phagocytes and inducibly in parenchymal, tissue-forming cells. <italic>In vitro</italic>, Perforin-2 prevents the intracellular replication and proliferation of bacterial pathogens in these cells. Perforin-2 knockout mice are unable to control the systemic dissemination of methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) or <italic>Salmonella typhimurium</italic> and perish shortly after epicutaneous or orogastric infection respectively. In contrast, Perforin-2-sufficient littermates clear the infection. Perforin-2 is a transmembrane protein of cytosolic vesicles -derived from multiple organelles- that translocate to and fuse with bacterium containing vesicles. Subsequently, Perforin-2 polymerizes and forms large clusters of 100Å pores in the bacterial surface with Perforin-2 cleavage products present in bacteria. Perforin-2 is also required for the bactericidal activity of reactive oxygen and nitrogen species and hydrolytic enzymes. Perforin-2 constitutes a novel and apparently essential bactericidal effector molecule of the innate immune system.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ryan M McCormack, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..</p></fn><fn fn-type="conflict" id="conf3"><p>Lesley R de Armas, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..</p></fn><fn fn-type="conflict" id="conf4"><p>Kirill Lyapichev, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..</p></fn><fn fn-type="conflict" id="conf5"><p>Eckhard R Podack, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#13-233 and #12-259) of the University of Miami Miller School of Medicine.</p></fn></fn-group></back></article>